Drug Shortage Report for SANDOZ TIMOLOL
Report ID | 179527 |
Drug Identification Number | 02166720 |
Brand name | SANDOZ TIMOLOL |
Common or Proper name | TIMOLOL SDZ 0.5% |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | TIMOLOL |
Strength(s) | 0.5% |
Dosage form(s) | SOLUTION |
Route of administration | OPHTHALMIC OPHTHALMIC |
Packaging size | 5ML |
ATC code | S01ED |
ATC description | ANTIGLAUCOMA PREPARATIONS AND MIOTICS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2022-12-22 |
Estimated end date | 2023-03-24 |
Actual end date | 2023-03-27 |
Shortage status | Resolved |
Updated date | 2023-03-28 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v13 | 2023-03-28 | English | Compare |
v12 | 2023-03-27 | French | Compare |
v11 | 2023-03-27 | English | Compare |
v10 | 2023-03-06 | French | Compare |
v9 | 2023-03-06 | English | Compare |
v8 | 2023-02-14 | French | Compare |
v7 | 2023-02-14 | English | Compare |
v6 | 2023-02-09 | French | Compare |
v5 | 2023-02-09 | English | Compare |
v4 | 2022-12-28 | French | Compare |
v3 | 2022-12-28 | English | Compare |
v2 | 2022-12-28 | English | Compare |
v1 | 2022-12-28 | English | Compare |
Showing 1 to 13 of 13